Drug Information

Drug General Information
Drug ID
D0W9QG
Former ID
DNCL001643
Drug Name
SBI-087
Synonyms
PF-05230895
Indication Multiple scierosis; Rheumatoid arthritis [ICD9: 340, 710-719, 714; ICD10:G35, M05-M06] Phase 2 [522841]
Company
Emergent BioSolutions; Pfizer
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info Inhibitor [544091]
KEGG Pathway Hematopoietic cell lineage
References
Ref 522841ClinicalTrials.gov (NCT01008852) Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis. U.S. National Institutes of Health.
Ref 544091Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immunol. 2009 August; 157(2): 198-208.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.